Gyl Financial Synergies, LLC Novartis Ag Transaction History

Gyl Financial Synergies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$92.57 - $107.37 $6,109 - $7,086	66 Added 1.96%	3,425 $364,000
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $952 - $1,084	10 Added 0.3%	3,359 $324,000
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $16,516 - $18,175	-179 Reduced 5.07%	3,349 $338,000
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $24,156 - $26,808	255 Added 7.79%	3,528 $359,000
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $302,817 - $343,370	3,273 New	3,273 $330,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $760,957 - $870,373	10,103 New	10,103 $971,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

Stay updated on Gyl Financial Synergies, LLC with notifications on news.